A breakthrough by scientists at Queen’s University Belfast could help reduce heart failure in cancer patients around the world, and ultimately increase survival rates.
Scientists at Queen’s Centre for Vision and Vascular Science have discovered …
Heart disease is a silent killer, but new microchip technology from Rice University is expected to advance the art of diagnosis.
During National Heart Health Month, Rice Professor John McDevitt will discuss the potential of this technology to dete…
Philadelphia, PA, February 8, 2011 — For the one in 200 adults in Western societies born with congenital heart disease, adult survivors face a lifelong process of medical interactions. Treatments received during neonatal, childhood, and adolescent…
New research from Warwick Medical School published today in the European Heart Journal shows that prolonged sleep deprivation and disrupted sleep patterns can have long-term, serious health implications. Leading academics from the University have l…
PORTLAND, Ore. — The pediatric cardiac team at Oregon Health & Science University Doernbecher Children’s Hospital is the first in the region and one of a handful in the nation to implant a pulmonary heart valve without open-heart surgery.
To date…
For almost two decades, cardiologists have searched for ways to see dangerous blood clots before they cause heart attacks.
Now, researchers at Washington University School of Medicine in St. Louis report that they have designed nanoparticles…
People who follow a vegan lifestyle — strict vegetarians who try to eat no meat or animal products of any kind — may increase their risk of developing blood clots and atherosclerosis or “hardening of the arteries,” which are conditions that ca…
The recalled Sprint Fidelis implantable cardioverter-defibrillator (ICD) leads (Medtronic) failed more often in younger patients, women, and individuals with hereditary heart disease, according to a multicenter study published online Jan. 17 in Circ…
LA JOLLA, CA — Scripps Research Institute scientists have converted adult skin cells directly into beating heart cells efficiently without having to first go through the laborious process of generating embryonic-like stem cells. The powerful gener…
Australian researchers have come one step closer to understanding how the rhythm of the heartbeat is controlled and why many common drugs, including some antibiotics, antihistamines and anti-psychotics, can cause a potentially fatal abnormal heart r…
A University of Manchester scientist has revealed the mechanism that binds skin cells tightly together, which he believes will lead to new treatments for painful and debilitating skin diseases and also lethal heart defects.
Professor David Garrod,…
STANFORD, Calif. — Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction (heart…
Cardiologists at the University of Connecticut Health Center have identified a protein fragment that when detected in the blood can be a predictor of heart attack.
Their research, led by Dr. Bruce Liang, director of the Pat and Jim Calhoun C…
A stack of punch cards from a landmark study published in 1966, and the legwork to track down the study’s participants years later, has yielded the longest analysis of the effects of lipoproteins on coronary heart disease.
The study, published in …
When faced with decisions, we often follow our intuition — our self-described “gut feelings” — without understanding why. Our ability to make hunch decisions varies considerably: Intuition can either be a useful ally or it can lead to costly and d…
DALLAS — Dec. 26, 2010 — New findings by UT Southwestern Medical Center researchers may solve a 17-year-old mystery about how the so-called “starvation hormone” affects multiple biological systems, including preventing insulin sensitivity and pr…
Las Vegas, NV (Dec. 24, 2010) – Three weeks of oral resveratrol or Longevinex® ingestion prior to an induced heart attack returned microRNA activity close to their pre-event levels in excised animal hearts. Among thousands of microRNA’s studied, ju…
TORONTO, Ont., Dec. 21, 2010 — St. Michael’s Hospital today became the first in Ontario to implant a small but powerful new defibrillator into a patient’s chest.
The defibrillator — about the size of a Zippo lighter — is the smallest availab…
